David Wellis, Ph.D.
Chief Executive Officer, San Diego Blood Bank
Dr. Wellis has over 25 years of experience in the life sciences and over 15 years in business development, marketing, and product commercialization in venture-backed startups to public companies. Currently, Dr. Wellis is the CEO of the San Diego Blood Bank. Previously, he was the President of BioAlta, a protein therapeutics company. Prior to BioAtla, Dr. Wellis headed Product Marketing at Illumina, Inc. and was responsible for managing hundreds of products for DNA and RNA analysis. He was president and CEO of GenVault Corporation, a company that provided innovative dry-state technologies to manage biological samples for research, diagnostic, and applied markets. Dr. Wellis began his commercial career at Axon Instruments, which developed novel instrumentation for biomedical research, drug discovery, and diagnostics.
Dr. Wellis received a BS from the UC Irvine, MS and PhD from Emory University, postdoctoral training at Tufts University Medical School and UC Berkeley, and business training at Leavey Business School of Santa Clara University and Haas Business School at UC Berkeley.
Dr. Wellis has been an active member of the Young President’s Organization since 2008.
Nikhil C. Panda, M.D.
Born and raised in San Diego, Dr. Panda graduated summa cum laude with an honors baccalaureate degree from Syracuse University, graduating as valedictorian of his department and performed his honors thesis with renowned cardiac electrophysiologist Dr. Charles Anztelevich. Dr. Panda then attended medical school at the SUNY Upstate Medical University College of Medicine in Syracuse, graduating with the Julius Schwartz Cardiology Award. Dr. Panda was then the single medical school graduate selected nationally to enter the Physician/Scientist Pathway at Case Western Reserve University, completing his residency in internal medicine and his fellowship in cardiology. In addition, Dr. Panda completed a three year postdoctoral research fellowship in cell therapy & tissue engineering for cardiac arrhythmias. Dr. Panda is now completing his advanced fellowship in clinical cardiac electrophysiology at New York-Presbyterian Hospital/Weill Cornell Medical Center of Cornell University in New York City. Dr. Panda has been funded by the National Institutes of Health, has multiple publications in peer reviewed journals, and has been an invited speaker at numerous regional and national meetings in the field of cardiac electrophysiology and regenerative medicine. He has won numerous awards for his research, including being a finalist for the Northwestern Cardiovascular Forum Young Investigator Award & placing first in overall research and winning the Young Investigator Award of the Ohio Chapter of the American College of Cardiology.
Greg Medley Pharm.D. MBA, CGP, FASCP
Sr. Director Pharmacy Services
Dr. Medley is an advocate of Accountable Care having spent his entire professional career providing expert evaluation and recommendation to patients and health care professionals about the appropriate drug use in older adults. Dr. Medley is a Commission Certified Geriatric Pharmacist, American Pharmaceutical Association Certified Medication Therapy Management Pharmacist, and a Fellow of the American Society of Consultant Pharmacists. Dr. Medley’s main focus is providing consultative services for collaborative drug therapy management, clinical pharmacy operations and administrative pharmacy operations where he was instrumental in implementing several pharmacy programs that have generated over $27M in savings for clients. Dr. Medley’s background in the business of pharmacy provides experience to develop, organize, implement, evaluate, and direct all pharmacy practice activity to conform to operational benchmarks. Dr. Medley actively develops change management strategy that serves to enhance the medical home model and clinical outcomes. Before becoming a health system pharmacy practice consultant, Dr. Medley was with the Scripps Health Corporate Pharmacy team where he operationalized a successful Medication Therapy Management program for Scripps Health, was Director of Clinical Pharmacy Services for Aspen Healthcare Metrics, was Director of Pharmacy at Continental Rehabilitation Hospital, was a Long Term Care Pharmacy Director at NCS Healthcare in San Diego, and most recently was an Associate Director in Navigant’s Healthcare Pharmaceutical and Life Sciences practice.
Dr. Josh Luke, FACHE
Founder, National Readmission Prevention Collaborative
Interim Chief Executive Officer, Memorial Hospital of Gardena
Executive Faculty, University of Southern California, Price School of Public Policy
Author: Readmission Prevention: Solutions Across the Provider Continuum
Dr. Josh Luke is a national thought-leader and international speaker on care coordination, population health management, readmission prevention and developing integrated post acute networks
He is an experienced hospital CEO, health system Vice President and nursing home administrator. Dr. Luke founded the National Readmission Prevention Collaborative (nationalreadmissionprevention.com) in October 2013 to showcase Best Practice integration models, working with health systems and communities nationwide to develop post acute networks and population health management strategies. Recent and past board appointments include The California Hospital Association Center for Post Acute Board of Directors, the Hospital Association of Southern California, Healthcare Executives of Southern California, CSULB Healthcare Administration Advisory Board, CareCentrix and Hospice Care of California. He is also a licensed SNF & RCFE Administrator and preceptor.